Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Compound dimetridazole premix for preventing and treating poultry enterovirus syndrome

A technology of enterotoxic syndrome and demenidazole, applied in application, drug combination, pharmaceutical formula, etc., can solve problems such as poor ventilation, excessive humidity, high density, etc., achieve no carcinogenic and teratogenic effects, and improve production , a wide range of effects

Active Publication Date: 2015-07-01
NANYANG XINXIANFENG PHARMA
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] ④The density is too high, the humidity is too high, and the ventilation is not good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: Weigh the raw materials respectively according to the following proportions: 20g of dimetridazole, 6g of neomycin sulfate, 4g of quinoxate, 20g of lysozyme, 1.5g of ethylamine sulfamate, 5g of lactic acid TMP, add anhydrous glucose to 100g, mix evenly, promptly make a kind of special-effect compound dipenidazole premix for treating avian enterotoxic syndrome. The raw materials are all commercially available products.

Embodiment 2

[0032] Example 2: Weigh the raw materials respectively according to the following proportions: 11g of dimenidazole, 9g of neomycin sulfate, 2g of quinoxyquinate, 30g of lysozyme, 1g of ethylamine sulfamate, 8g of lactic acid TMP, and add anhydrous glucose to 100g and mix evenly to prepare a special-effect compound dimenidazole premix for treating poultry enterotoxic syndrome. The raw materials are all commercially available products.

Embodiment 3

[0033] Example 3: Weigh the raw materials respectively according to the following proportions: 30g of demetonidazole, 4g of neomycin sulfate, 7g of quinoxyquinate, 12g of lysozyme, 4g of ethylamine sulfamate, 4g of lactic acid TMP, and add anhydrous glucose to 100g and mix evenly to prepare a special-effect compound dimenidazole premix for treating poultry enterotoxic syndrome. The raw materials are all commercially available products.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound dimetridazole premix for preventing and treating the poultry enterovirus syndrome. The premix is prepared by uniformly mixing the following components in percentage by weight: 10 to 30 percent of dimetridazole, 4 to 10 percent of neomycin sulfate, 2 to 8 percent of decoquinate econazole nitrate, 10 to 30 percent of lysozyme, 0.5 to 5 percent of etamsylate, 3 to 10 percent of lactic acid TMP and the balance of pharmaceutically applicable auxiliary material. According to the invention, the novel high-efficiency anticoccidial drug decoquinate econazole nitrate, the dimetridazole and the neomycin sulfate which have a special curative effect on intestinal infection, the lysozyme with effects of resisting to bacteria, resisting to viruses, diminishing inflammation, relieving pain and repairing intestinal mucosa, the high-efficiency hemostatics etamsylate and the drug synergist are compounded into a compound preparation; and the compound dimetridazole premix has a high-efficiency treatment effect on the poultry enterovirus syndrome. The compound dimetridazole premix has a reasonable and scientific formula, is simple to prepare, has wide application and can be used as a priority drug for preventing and treating the poultry enterovirus syndrome.

Description

technical field [0001] The invention relates to a medicine for poultry, in particular to a compound dimenidazole premix for preventing and treating poultry enterotoxic syndrome. Background technique [0002] At present, with the high-density and intensive development of the aquaculture industry, a big problem has emerged in areas where the aquaculture industry is developed in our country. Whether it is flat farming on the ground or online, whether it is broiler or layer hens, it is common in chicken flocks. A disease characterized by diarrhea, feces containing incompletely digested feed or persimmon-red feces, decreased feed intake, weight loss, dehydration, decreased feed remuneration, and tomato-like contents in the intestinal tract at autopsy. At present, the disease is prevalent. Although the mortality rate is not high, the hidden economic loss caused is huge, and farmers mistakenly think it is "dyspepsia" or misdiagnosed as coccidia small intestine. Studies have shown ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/47A23K1/16A61P1/12A61P1/00A61K31/4164A61K31/7036A61K31/205A61K31/505
Inventor 刘长斗曹素芳
Owner NANYANG XINXIANFENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products